Postpartum Depressive Symptoms Among Women with Elevated Prenatal Anxiety in Kazakhstan: Prospective Observational Cohort Study
Postpartale depressive Symptome bei Frauen mit erhöhter pränataler Angst in Kasachstan: prospektive Beobachtungskohortenstudie
Journal of Clinical Medicine · 27.07.2026 · 15 (15) · 5869
DOI: 10.3390/jcm15155869 ↗Auf einen Blick
Bei 226 Frauen mit erhöhter pränataler Angst waren postpartale depressive Symptome häufig. 69,9 % screenten positiv nach PDSS-SF; die höchsten Werte traten 6 Wochen bis 6 Monate postpartum auf.
Fragestellung
Wie häufig sind postpartale depressive Symptome bei Frauen mit erhöhter pränataler Angst in Kasachstan, und mit welchen Faktoren sind sie assoziiert?
Methode
Prospektive einarmige Kohortenstudie mit postpartalem Follow-up in Astana, Kasachstan; 226 Frauen mit erhöhter pränataler Angst; PDSS-SF; Assoziationen mit Alter, Parität und Zeitpunkt der Nachuntersuchung.
Ergebnisse
Mittlerer PDSS-SF-Score 20,65 ± 6,00. Bei Cut-off ≥17 waren 158/226 positiv, entsprechend 69,9 % (95 %-KI 63,6–75,5 %). Höchste Werte 6 Wochen bis 6 Monate postpartum (p < 0,001).
Einschränkungen
Keine Kontrollgruppe; die Studie war nicht zur Bewertung der Wirksamkeit von PRISM oder kausaler Effekte angelegt.
Schlussfolgerung der Autor:innen
Es wurde eine erhebliche Belastung durch postpartale depressive Symptome in dieser Hochrisikogruppe beobachtet. Die Autor:innen sehen Bedarf für frühe Erkennung pränataler Angst, fortgesetztes Screening und geeignete Versorgung.
Kernaussagen
- 69,9 % der 226 Frauen screenten positiv auf klinisch relevante Symptome
- Die höchsten Werte traten 6 Wochen bis 6 Monate postpartum auf
- Alter war schwach negativ korreliert; Parität nicht signifikant assoziiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.07.2026. Verfasst von Gulzhanat Aitmurzinova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathological Physiology, Astana Medical University, Astana 010000, Kazakhstan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Postpartum depression (PPD) is a common mental health condition, and women with elevated prenatal anxiety are at increased risk. Evidence from Kazakhstan remains limited. This study aimed to describe postpartum depressive symptoms and associated factors among women with elevated prenatal anxiety who received routine perinatal care and participated in the PRISM prenatal psychoeducational program.
Methods
This prospective single-arm cohort study with postpartum follow-up was conducted in Astana, Kazakhstan. Of 1232 pregnant women screened, 234 women with elevated prenatal anxiety participated in the PRISM program, and 226 completed the postpartum assessment. Because no control group was included, the study was not designed to evaluate the effectiveness of PRISM or establish causal effects. Postpartum depressive symptoms were assessed using the Postpartum Depression Screening Scale–Short Form (PDSS-SF). Descriptive statistics were calculated, and associations with age, parity, and postpartum assessment period were examined using Spearman’s rank correlation and non-parametric tests.
Results
The mean PDSS-SF score was 20.65 ± 6.00. Using a cut-off score of ≥17, 158 of 226 participants screened positive for clinically significant depressive symptoms, corresponding to 69.9% (95% confidence interval (CI): 63.6–75.5%). Scores were highest among women assessed between 6 weeks and 6 months postpartum (p < 0.001). Age showed a weak negative correlation with depressive symptoms, whereas parity was not significantly associated. The most frequently reported symptoms were sleep disturbance, loneliness, and depressed mood.
Conclusions
A substantial burden of postpartum depressive symptoms was observed in this high-risk cohort. The findings support early identification of prenatal anxiety, continued postpartum screening, and access to appropriate psychological and psychiatric care. Controlled studies are needed to evaluate PRISM and similar preventive programs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathological Physiology, Astana Medical University, Astana 010000, Kazakhstan.
- Department of Radiation Diagnostics, Center of Nuclear Medicine and Oncology of Abai Region, Semey 071400, Kazakhstan.
- Department of General Medical Practice, Semey Medical University, Semey 071400, Kazakhstan.
- Department of Nursing, Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan.
- Higher Medical College of the Public Health Department of Almaty, Almaty 050020, Kazakhstan.
ORCID-Profile: Arailym Baurzhan, Akmaral Mussakhanova, Fatima Bagiyarova
Zitieren
APA
Aitmurzinova, G., Baurzhan, A., Mussakhanova, A., Shalgumbayeva, G., Issenova, B., Bagiyarova, F., Tanatarov, S., Yermentayeva, L., Arinova, S., Rakhmatullina, N., & Kassymova, A. (2026). Postpartum Depressive Symptoms Among Women with Elevated Prenatal Anxiety in Kazakhstan: Prospective Observational Cohort Study. Journal of Clinical Medicine, 15(15), 5869. https://doi.org/10.3390/jcm15155869
Vancouver
Aitmurzinova G, Baurzhan A, Mussakhanova A, Shalgumbayeva G, Issenova B, Bagiyarova F, et al. Postpartum Depressive Symptoms Among Women with Elevated Prenatal Anxiety in Kazakhstan: Prospective Observational Cohort Study. Journal of Clinical Medicine. 2026;15(15):5869. doi:10.3390/jcm15155869
BibTeX
@article{Aitmurzinova2026,
author = {Aitmurzinova, Gulzhanat and Baurzhan, Arailym and Mussakhanova, Akmaral and Shalgumbayeva, Gulnar and Issenova, Balday and Bagiyarova, Fatima and Tanatarov, Sayat and Yermentayeva, Lazzat and Arinova, Saparkul and Rakhmatullina, Naslizat and Kassymova, Aida},
title = {Postpartum Depressive Symptoms Among Women with Elevated Prenatal Anxiety in Kazakhstan: Prospective Observational Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {5869},
doi = {10.3390/jcm15155869}
}
EUVIMED